Reduction of experimental laser-induced choroidal neovascularization by orally administered BPHA, a selective metalloproteinase inhibitor

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 241, Issue 11, 2003, Pages 943-952

  Kohri, Takashi ^a   Moriwaki, Mitsuyasu ^b   Nakajima, Masatoshi ^c   Tabuchi, Hitoshi ^a   Shiraki, Kunihiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka City Juso Hospital   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; ENZYME PRECURSOR; GELATINASE; GELATINASE A; GELATINASE B; GELATINASE INHIBITOR; HYDROXAMIC ACID; HYDROXAMIC ACID DERIVATIVE; MATRIX METALLOPROTEINASE 14; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; N BIPHENYL SULFONYL PHENYLALANINE HYDROXAMIC ACID; N BIPHENYLSULFONYLPHENYLALANINE HYDROXAMIC ACID; N-BIPHENYLSULFONYLPHENYLALANINE HYDROXAMIC ACID; PROGELATINASE; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIODE LASER; DOSE RESPONSE; DRUG ACTIVITY; DRUG SELECTIVITY; ENZYME ACTIVITY; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LASER; LASER COAGULATION; MALE; METABOLISM; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION INJURY; RAT; RAT STRAIN; SCORING SYSTEM; STATISTICAL ANALYSIS; SUBRETINAL NEOVASCULARIZATION; WEIGHT GAIN; ZYMOGRAPHY;

ADMINISTRATION, ORAL; ANIMALS; CHOROIDAL NEOVASCULARIZATION; ENZYME INHIBITORS; ENZYME PRECURSORS; FLUORESCEIN ANGIOGRAPHY; GELATINASES; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; LASERS; MALE; METALLOENDOPEPTIDASES; METALLOPROTEASES; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, INBRED BN; WEIGHT GAIN;

EID: 0347531766     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-003-0761-2     Document Type: Article

References (28)

1. Ciulla TA, Danis RP, Harris A (1998) Age-related macular degeneration: a review of experimental treatments. Surv Ophthalmol 43:134-146
2. Chong NH, Bird AC (1998) Alternative therapies in exudative age related macular degeneration [review]. Br J Ophthalmol 82:1441-1443
3. Das A, Puklin JE, Frank RN, Zhang NL (1992) Ultrastructural immunocytochemistry of subretinal neovascular membranes in age-related macular degeneration. Ophthalmology 99:1368-1376
4. Denis LJ, Verweij J (1997) Matrix metalloproteinase inhibitors: present achievement and future prospects. Invest New Drugs 15:175-185
5. Dobi ET, Puliafito CA, Destro M (1989) A new model of experimental choroidal neovascularization in the rat. Arch Ophthalmol 107:264-269
6. Eckardt C, Eckardt U, Conrad HG (1999) Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 237:313-325
7. Galis ZS, Sukhova GK, Libby P (1995) Microscopic localization of active proteases by in situ zymograpy: detection of matrix metalloproteinase activity in vascular tissue. FASEB J 9:974-980
8. Green WR, Key SN III (1977) Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc 75:180-254
9. Ikeda M, Maekawa R, Tanaka H, Matsumoto M, Takeda Y, Tamura Y, Nemori R, Yoshioka T (2000) Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography. Clin Cancer Res 6:3290-3296
10. Juan E de Jr, Loewenstein A, Bressler NM, Alexander J (1998) Translocation of the retina for management of subfoveal choroidal neovascularization II: a preliminary report in humans. Am J Ophthalmol 125:635-646
11. Knox JB, Sukhova GK, Whittemore AD, Libby P (1997) Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic disease. Circulation 95:205-212
12. Krejci-Papa NC, Pans R (1998) A novel in-situ-zymography technique localizes gelatiolytic activity in human skin to mast cells. Exp Dermatol 7:321-326
13. Kvanta A, Shen WY, Sarman S, Seregard S, Steen B, Rakoczy E (2000) Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. Curr Eye Res 21:684-690
14. Lewis H, Kaiser PK, Lewis S, Estafanous M (1999) Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study. Am J Ophthalmol 128:135-146
15. Macular Photocoagulation Study Group (1990) Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol 108:825-831
16. Mignatti P, Rifkin DB (1996) Plasminogen activators and matrix metalloproteinases in angiogenesis enzyme protein 49:117-137
17. Mungall BA, Pollitt CC, Collins R (1998) Localization of gelatinase activity in epidermal hoof lamellae by in situ zymography. Histochem Cell Biol 110:535-540
18. Murata T, Cui J, Taba KE, Oh JY, Spee C, Hinton DR, Ryan SJ (2000) The possibility of gene therapy for the treatment of choroidal neovascularization. Ophthalmology 107:1364-1373
19. Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y (1999) Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res 59:467-473
20. Nemunaitis J, Poole C, Primrose J, Rosemurgy A, Malfetano J, Brown P, Berrington H, Cornish A, Lynch K, Rasmussen H, Kerr D, Cox D, Millar A (1998) Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of biologically active and tolerable dose for longer-term studies. Clin Cancer Res 4:1101-1109
21. Pepper MS, Montesano R (1990) Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32:319-327
22. Reichel E, Berrocal AM, Ip M, Kroll AJ, Desai V, Duker JS, Puliafito CA (1999) Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology 106:1908-1914
23. Maekawa R, Maki H, Yoshida H, Hojo K, Tanaka H, Wada T, Uchida N, Takeda Y, Kasai H, Okamoto H, Tsuzuki H, Kambayashi Y, Watanabe F, Kawada K, Toda K, Ohtani M, Sugita K, Yoshioka T (1999) Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxamic acid (BPHA), an orally active, selective matrix metalloproteinase inhibitor. Cancer Res 59:1231-1235
24. Sarks SH (1973) New vessel formation beneath the retinal pigment epithelium in senile eyes. Br J Ophthalmol 57:951-965
25. Schmidt-Erfurth U, Michels S, Barbazetto I, Laqua H (2002) Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci 43:830-841
26. Takehana Y, Kurokawa T, Kitamura T, Tsukahara Y, Akahane S, Kitazawa M, Yoshimura N (1999) Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat. Invest Ophthalmol Vis Sci 40:459-466
27. Tamura Y, Watanabe H, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M (1998) Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives. J Med Chem 41:640-649
28. Wojtowicz-Praga S, Torri J, Johnson M, Steen V, Marshall J, Ness E, Dickson R, Sale M, Rasmussen HS, Chiodo TA, Hawkins MJ (1998) Phase I trial of marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. J Clin Oncol 16:2150-2156